Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT07320118
NCT07320118RecruitingNot Applicable

Cell Therapy for Osteoarthritis

Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust2 sites in 1 country650 target enrollmentStarted: April 13, 2010Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
650
Locations
2
Primary Endpoint
Cell Therapy Questionnaire
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Observational study to assess the effectiveness of cell therapy for the treatment of osteoarthritis

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •ACI patients or patients receiving an alternative treatment

Exclusion Criteria

  • •Anyone who does not meet the inclusion criteria

Outcomes

Primary Outcomes

Cell Therapy Questionnaire

Time Frame: At least fifteen months post operation

Cell Therapy Questionnaire CTQ

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust
Sponsor Class
Other Gov
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Active, not recruiting
Not Applicable
Autologous Stem cells, Chondrocytes Or the Two?Symptomatic cartilage defects in the kneeMusculoskeletal DiseasesArthritis
ISRCTN98997175Robert Jones and Agnes Hunt Orthopaedic Hospital (UK)114
Active, not recruiting
Not Applicable
A comparison of two different cell types for treating osteoarthritis in the knee.osteochondral defects of the knee (early osteoarthritis)MedDRA version: 14.1Level: LLTClassification code 10023476Term: Knee osteoarthritisSystem Organ Class: 100000004859
EUCTR2010-022072-31-GBRJAH Orthopaedic Hospital114
Not yet recruiting
Phase 2
Role of platelet rich plasma in Osteoarthritis knee
CTRI/2023/10/058367Jnmc40
Recruiting
Phase 2
Methotrexate treatment in hand osteoarthritis refractory to usual treatments
2022-502362-24-00Centre Hospitalier Universitaire De Nice170
Unknown
Phase 2
PRP-HA Versus HA in Knee OsteoarthritisOsteoarthritis, Knee
NCT05076526Singapore General Hospital132